Experienced in Acute Lymphoblastic Leukemia (ALL)

Deok-hwan C. Yang

Hwasun, KR 
Experienced in Acute Lymphoblastic Leukemia (ALL)
Hwasun, KR 
OverviewLocationsClinical Research

Overview

Deok-hwan Yang practices in Hwasun, Republic of Korea. Yang is rated as an Experienced expert by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). Their top areas of expertise are Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), B-Cell Lymphoma, Peripheral T-Cell Lymphoma, and Bone Marrow Transplant.

Their clinical research consists of co-authoring 172 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 10 articles and participated in 1 clinical trial in the study of Acute Lymphoblastic Leukemia (ALL).

Locations

Hwasun, Republic of Korea
Other Locations
Gwangju, Republic of Korea
Ulsan, Republic of Korea

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

An Open-label, Single-arm, Phase 2 Study to Investigate the Efficacy and Safety of IMC-001 in Patients With Relapsed or Refractory Extranodal NK/T Cell Lymphoma, Nasal Type
An Open-label, Single-arm, Phase 2 Study to Investigate the Efficacy and Safety of IMC-001 in Patients With Relapsed or Refractory Extranodal NK/T Cell Lymphoma, Nasal Type
Enrollment Status: Active_not_recruiting
Publish Date: June 18, 2025
Intervention Type: Drug
Study Drug: IMC-001
Study Phase: Phase 2
An International, Phase 2, Open-Label, Randomized Study of BGB-3111 Combined With Obinutuzumab Compared With Obinutuzumab Monotherapy in Relapsed/ Refractory Follicular Lymphoma
An International, Phase 2, Open-Label, Randomized Study of BGB-3111 Combined With Obinutuzumab Compared With Obinutuzumab Monotherapy in Relapsed/ Refractory Follicular Lymphoma
Enrollment Status: Completed
Publish Date: January 23, 2025
Intervention Type: Drug
Study Drugs: Zanubrutinib, Obinutuzumab
Study Phase: Phase 2
A Multi-center, Single-arm, Open, Phase I/IIa Clinical Trial to Evaluate the Efficacy and Safety of EBViNT Cell (EBV Specific Autologous CD8+ T Cell) in Patients With Treatment Failed Epstein Barr Virus (EBV)-Positive Malignancies
A Multi-center, Single-arm, Open, Phase I/IIa Clinical Trial to Evaluate the Efficacy and Safety of EBViNT Cell (EBV Specific Autologous CD8+ T Cell) in Patients With Treatment Failed Epstein Barr Virus (EBV)-Positive Malignancies
Enrollment Status: Unknown
Publish Date: July 11, 2022
Intervention Type: Biological
Study Drug: EBViNT Cell
Study Phase: Phase 1/Phase 2
Phase 2 Study Evaluating the Efficacy of Rituximab Plus Modified VPDL for Newly Diagnosed CD20-Positive Adult Acute Lymphoblastic Leukemia
Phase 2 Study Evaluating the Efficacy of Rituximab Plus Modified VPDL for Newly Diagnosed CD20-Positive Adult Acute Lymphoblastic Leukemia
Enrollment Status: Unknown
Publish Date: July 24, 2018
Intervention Type: Drug
Study Drugs: Rituximab, Modified VPDL
Study Phase: Phase 2
View 3 Less Clinical Trials

172 Total Publications

Efficacy and Safety of Ropeginterferon Alfa-2b in Low-Risk Polycythemia Vera.
Efficacy and Safety of Ropeginterferon Alfa-2b in Low-Risk Polycythemia Vera.
Journal: Cancer research and treatment
Published: May 23, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Yang's expertise for a condition
ConditionClose
    View All 9 Advanced Conditions
    View All 20 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile